Executive Functions and Reinforcement Sensitivity in Women With Obsessive Compulsive Symptoms

January 11, 2020 updated by: Malahat Amani

University of Bojnord

Methods: The study population consisted of all adult women living in Sabzevar city (Iran). Using cluster sampling, 365 women were selected as the study sample. Participants completed Obsessive-Compulsive Inventory, Sensitivity to Punishment and Sensitivity to Reward Questionnaire - Revised and Clarified (SPSRQ-RC) as well as Behavior Rating Inventory of Executive Function (BRIEF). Data analysis was conducted using correlation and regression tests.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

365

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 52 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

The statistical population consisted of all adult women living in Sabzevar city in 2019. The sampling was conducted using cluster sampling method. In randomly selected areas, participants were selected from among local women

Description

Inclusion Criteria:

having age between 18 to 54, be female, be literacy,

Exclusion Criteria:

be male, be illiteracy, having psychotic disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
executive functions
Time Frame: 1 month
It was measured by behavior rating inventory of executive function. it consists of 75 items that are measured on a 5-point Likert scale. subscales include inhibition, shift, emotional control, self-monitoring, initiation, working memory, planning/organization, task monitoring and organization of materials. min and max scores are 0 and 150. respectively. the higher scores indicate problems in executive functions.
1 month
obsessive-compulsive symptom
Time Frame: 1 month
it was measured by the Obsessive-Compulsive Inventory. This inventory contains 42 items that are measured on a 5-point Likert scale. It consists of the sub-scales of washing, controlling, doubting, ordering, obsession, hoarding, and neutralizing. the higher scores are probably an indicator of obsessive-compulsive disorder.
1 month
reinforcement sensitivity
Time Frame: 1 month
it was measured by Sensitivity to Punishment and Sensitivity to Reward Questionnaire: This 20-item scale measures sensitivity to reward and sensitivity to punishment, which is scored on a 5-point Likert scale (from "totally correct" to "totally incorrect"). the higher scores in subscales of sensitivity to punishment and Sensitivity to Reward indicate high activity in punishment and reward systems.
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2019

Primary Completion (Actual)

November 1, 2019

Study Completion (Actual)

December 22, 2019

Study Registration Dates

First Submitted

January 6, 2020

First Submitted That Met QC Criteria

January 6, 2020

First Posted (Actual)

January 9, 2020

Study Record Updates

Last Update Posted (Actual)

January 14, 2020

Last Update Submitted That Met QC Criteria

January 11, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 131820

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Executive Dysfunction

Clinical Trials on descriptive

3
Subscribe